Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead

Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities

(2019) Christopher M Parry et al.   BMJ-British Medical Journal

Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine

(2019) Bernie Endyarni Medise et al.   PLoS One

The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017

(2019) Jeffrey D Stanaway et al.   LANCET INFECTIOUS DISEASES

Typhoid vaccines: WHO position paper, March 2018 – Recommendations

(2018) World Health Organization   VACCINE

Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children

(2018) Maria Rosario Capeding et al.   VACCINE

Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins

(2018) Elizabeth J. Klemm et al.   mBio

Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans

(2018) Sushant Sahastrabuddhe et al.   CLINICAL INFECTIOUS DISEASES

Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial

(2017) Celina Jin et al.   LANCET

The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, Oxford, UK

(2017) James E. Meiring et al.   VACCINE

Polysaccharide conjugate vaccine protein carriers as a “neglected valency” – Potential and limitations

(2017) Michael Bröker et al.   VACCINE

A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions

(2017) Vittal Mogasale et al.   Human Vaccines & Immunotherapeutics

The burden of typhoid fever in low- and middle-income countries: A meta-regression approach

(2017) Marina Antillón et al.   PLoS Neglected Tropical Diseases

Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study

(2017) Florian Marks et al.   Lancet Global Health

Updated estimates of typhoid fever burden in sub-Saharan Africa

(2017) Jong-Hoon Kim et al.   Lancet Global Health

Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study

(2016) Monjori Mitra et al.   Human Vaccines & Immunotherapeutics

The Burden of Typhoid and Paratyphoid in India: Systematic Review and Meta-analysis

(2016) Jacob John et al.   PLoS Neglected Tropical Diseases

Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a

(2016) Thomas C. Darton et al.   PLoS Neglected Tropical Diseases

Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies

(2015) Vittal Mogasale et al.   BMC INFECTIOUS DISEASES

Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study

(2015) Vadrevu Krishna Mohan et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections

(2015) John A. Crump et al.   CLINICAL MICROBIOLOGY REVIEWS

Conjugate-like immunogens produced as protein capsular matrix vaccines

(2015) Ann Thanawastien et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Typhoid fever vaccination strategies

(2015) Kashmira A. Date et al.   VACCINE

Live attenuated vaccines for invasive Salmonella infections

(2015) Sharon M. Tennant et al.   VACCINE

World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis

(2015) Martyn D. Kirk et al.   PLOS MEDICINE

Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment

(2014) Vittal Mogasale et al.   Lancet Global Health

Increasing rates ofSalmonellaParatyphi A and the current status of its vaccine development

(2013) Sushant Sahastrabuddhe et al.   Expert Review of Vaccines

Development of Vi conjugate – a new generation of typhoid vaccine

(2013) Shousun Chen Szu   Expert Review of Vaccines

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

(2013) Zulfiqar A Bhutta et al.   LANCET INFECTIOUS DISEASES

Sustained Protection in Mice Immunized with Fractional Doses of Salmonella Enteritidis Core and O Polysaccharide-Flagellin Glycoconjugates

(2013) Raphael Simon et al.   PLoS One

Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010

(2012) Geoffrey C. Buckle et al.   Journal of Global Health

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

(2011) Vu Dinh Thiem et al.   Clinical and Vaccine Immunology

Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults

(2011) Pierre van Damme et al.   PLoS One

Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD− S. Typhi-specific IgA and IgG B memory cells in humans

(2010) Rezwanul Wahid et al.   CLINICAL IMMUNOLOGY

A Randomised Trial Evaluating the Safety and Immunogenicity of the Novel Single Oral Dose Typhoid Vaccine M01ZH09 in Healthy Vietnamese Children

(2010) Tran Tinh Hien et al.   PLoS One

Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi

(2010) F. Micoli et al.   VACCINE

Physical and Chemical Characterization and Immunologic Properties of Salmonella enterica Serovar Typhi Capsular Polysaccharide-Diphtheria Toxoid Conjugates

(2009) C. Cui et al.   Clinical and Vaccine Immunology

a study of typhoid fever in five Asian countries: disease burden and implications for controls

(2008) R Leon Ochiai   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Gram-negative outer membrane vesicles: beyond the cell surface

(2008) L MASHBURN-WARREN et al.   Geobiology